Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Martin

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Future Oncology (London, England)|January 23, 2026
Plain language summary of the management of certain side effects of teclistamab in people with multiple myelomaThomas G Martin, Niels W C J van de Donk, Paula Rodríguez-Otero, et al.
Hospital Pharmacy|June 26, 2024
An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021Shawn M Varney, Sarah Watkins, Haylea Stuteville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2013
Phase Ib dose-escalation study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myelomaRuben Niesvizky, Thomas G Martin, William I Bensinger, et al.
Current Problems in Cancer|February 22, 2023
Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain AmyloidosisVanessa E Kennedy, Kelsey Natsuhara, Sireesha A Maringanti, et al.
Ejhaem|July 18, 2022
Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantationRahul Banerjee, Ann A Lazar, Lisa Dunn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2019
Impact of Plerixafor Use at Different Peripheral Blood CD34<sup>+</sup> Thresholds on Autologous Stem Cell Collection in Patients with Multiple MyelomaEshana E Shah, Rebecca P Young, Sandy W Wong, et al.
British Journal of Haematology|February 27, 2023
Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective studyAlex Y Ge, Chiung-Yu Huang, Rahul Banerjee, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 16, 2019
The Role of Volume Regulation and Thermoregulation in AKI during Marathon RunningSherry G Mansour, Thomas G Martin, Wassim Obeid, et al.
Transplantation and Cellular Therapy|April 8, 2021
Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in MyelomaRahul Banerjee, Jeffrey Marsal, Chiung-Yu Huang, et al.
Oncology and Therapy|June 4, 2023
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple MyelomaStephen Palmer, Yi Lin, Thomas G Martin, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Future Oncology (London, England)|January 23, 2026
Plain language summary of the management of certain side effects of teclistamab in people with multiple myelomaThomas G Martin, Niels W C J van de Donk, Paula Rodríguez-Otero, et al.
Hospital Pharmacy|June 26, 2024
An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021Shawn M Varney, Sarah Watkins, Haylea Stuteville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2013
Phase Ib dose-escalation study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myelomaRuben Niesvizky, Thomas G Martin, William I Bensinger, et al.
Current Problems in Cancer|February 22, 2023
Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain AmyloidosisVanessa E Kennedy, Kelsey Natsuhara, Sireesha A Maringanti, et al.
Ejhaem|July 18, 2022
Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantationRahul Banerjee, Ann A Lazar, Lisa Dunn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2019
Impact of Plerixafor Use at Different Peripheral Blood CD34<sup>+</sup> Thresholds on Autologous Stem Cell Collection in Patients with Multiple MyelomaEshana E Shah, Rebecca P Young, Sandy W Wong, et al.
British Journal of Haematology|February 27, 2023
Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective studyAlex Y Ge, Chiung-Yu Huang, Rahul Banerjee, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 16, 2019
The Role of Volume Regulation and Thermoregulation in AKI during Marathon RunningSherry G Mansour, Thomas G Martin, Wassim Obeid, et al.
Transplantation and Cellular Therapy|April 8, 2021
Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in MyelomaRahul Banerjee, Jeffrey Marsal, Chiung-Yu Huang, et al.
Oncology and Therapy|June 4, 2023
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple MyelomaStephen Palmer, Yi Lin, Thomas G Martin, et al.
Pageof 14